Abstract: A method is provided to protect against ill-behaved microcode by balancing between an actual occurrence of a hardware problem and a microcode bug setting a flag appearing as a hardware problem. In this method, the error recovery is performed only on a single piece of hardware and no further error recovery action is taken on other pieces of similar hardware. The approach addresses the problem by treating a hit on one card as a hardware problem, but as a bug on subsequent cards. The invention keeps track of whether or not the same event has occurred on the same type of hardware so not to take action on more than one instance of the hardware. Subsequent hits on another instance of the hardware will not trigger the hardware related recovery on additional hardware.

Abstract: The present invention relates to monosaccharide derivatives as anti-inflammatory agents. The compounds disclosed herein can be useful for inhibition and prevention of inflammation and associated pathologies including inflammatory, cancer, cardiovascular and autoimmune diseases such as bronchial asthma, rheumatoid arthritis, type-I diabetes, multiple sclerosis, allograft rejection, psoriasis, inflammatory bowel disease, ulcerative colitis, acne, atherosclerosis, pruritis or allergic rhinitis. Pharmacological compositions containing compounds disclosed herein and the methods of treating diseases such as bronchial asthma, rheumatoid arthritis, type-I diabetes, multiple sclerosis, cancer, cardiovascular diseases, allograft rejection, psoriasis, inflammatory bowel disease, ulcerative colitis, acne, atherosclerosis, pruritis or allergic rhinitis and other inflammatory and/or autoimmune disorders, using the compounds are also provided.

Abstract: In order to synthesize semi-interpenetrating polymer networks (semi-IPNs) with molecular sieve characteristics, polyetherimide/bismaleimide (PEI/BMI) chromophore composites were made through sol-gel technique. A tunable and compatible chemical structure with fine morphology was obtained through in situ controlled sol-gel polymerization, crosslinking, chemical modification and membrane fabrication. The novel semi-IPN, synthesized and assembled by using ethanol as polar protic modifier and pore former, had a superior structure and morphology suitable for making gas separation membranes. These semi-IPN membranes gave fifteen times higher gas flux without significant decrease in their gas permselectivity than membranes prepared from pure PEL The chemical structures of these novel semi-IPNs were characterized by using FTIR, XPS and SEM.

Abstract: The present invention relates to an aromatic substituted pentadienoic acid amides and there use in combination of specific amounts of aromatic amides i.e. 4-alkyl-5-(substituted phenyl)-2(E),4(E)-pentadienoic acid amides, its geometrical isomers or their dihydro or tetrahydro derivatives and an anti-infective drug useful in potentiating the bioefficacy of antiinfective drug. The combination of the present invention is useful in the treatment of certain infections and disease at lower concentration of anti-infectives necessary to inhibit the growth of microbial strains and may also find applications in reducing the resistance in microorganisms.

Abstract: The invention disclosed relates to feed spacers used in various filtration membrane modules, such as in spiral wound membranes, used in cross-flow filtration. Such spacers have an influence in promoting the mixing between the bulk of the fluid and the fluid element adjacent to the membrane surface so as to keep the membrane surface relatively clean. To optimize these properties, novel spacer designs are disclosed having a plurality of rows of elongated strands, the strands in each row being arranged substantially in parallel to one another, with adjacent rows being attached and disposed at an angle to one another, the strands of at least one row when viewed in cross-section having a central portion of a width smaller than the width of its extremities. Novel membrane modules incorporating such feed spacers are also disclosed.

Abstract: The present invention relates to a composition useful for hepatoprotection, said composition comprising polar extract of plant Cryptolepis Buchanani and/or fractions of the said extract, and optionally pharmaceutically acceptable additives and a method of producing said composition and also a method of treating a subject using said composition.

Abstract: Methods for producing azole compounds useful as intermediates for antifungal compounds and compositions including reaction of epoxy alcohols with reactants having active hydrogen attached to nitrogen, oxygen or sulfur in the presence of redox coupling agents. In some embodiments, a procedure known as a Mitsunobu reaction is utilized for the transformations.

Abstract: The present invention relates to the derivatives of specially substituted azole compounds which have improved anti-fungal activity as compared with presently available agents in this class and the processes for the preparation thereof. This invention also relates to pharmaceutical preparations containing the compounds of the present invention and their use in treating and/or preventing the fungal infections in mammals, preferably humans.

Abstract: The invention disclosed relates to feed spacers used in various filtration membrane modules, such as in spiral wound membranes, used in cross-flow filtration. Such spacers have an influence in promoting the mixing between the bulk of the fluid and the fluid element adjacent to the membrane surface so as to keep the membrane surface relatively clean. To optimize these properties, novel spacer designs are disclosed having a plurality of rows of elongated strands, the strands in each row being arranged substantially in parallel to one another, with adjacent rows being attached and disposed at an angle to one another, the strands of at least one row when viewed in cross-section having a central portion of a width smaller than the width of its extremities. Novel membrane modules incorporating such feed spacers are also disclosed.

Abstract: A microbial decontaminator device for decontaminating herbal and/or pharmaceutical products, the said decontamination device comprising of a microwave oven provided with two slots, one on a front face and the other on a rear face of the microwave oven, a conveyor belt passing through the microwave oven through the two slots and provided with a driving means for driving the conveyor belt, said driving means being coupled to a computer which controls the driving means and in turn, the conveyor belt, the assembly of the microwave oven, the conveyor belt and the driving means being covered by a shielding cage to prevent leakage of microwave radiation to atmosphere, a feed hopper provided behind the rear face of the microwave oven and the conveyor belt for feeding the product to be decontaminated, and an output chute being provided below the conveyor belt and in front of the front face of the microwave oven for collecting the decontaminated product.

Abstract: Disclosed are a method, apparatus, and computer program product to reduce the detrimental effects of taking resources offline. A resource is taken offline in a storage network by quiescing activity to the resource providing notification that the resource will become unavailable, and taking the resource offline.

Abstract: The present invention relates to a composition useful for hepatoprotection, said composition comprising polar extract of plant Cryptolepis Buchanani and/or fractions of the said extract, and optionally pharmaceutically acceptable additives and a method of producing said composition and also a method of treating a subject using said composition.

Abstract: The present invention relates to the derivatives of specially substituted azole compounds which have improved antifungal activity as compared with presently available agents in this class and the processes for the preparation thereof. This invention also relates to pharmaceutical preparations containing the compounds of the present invention and their use in treating and/or preventing the fungal infections in mammals, preferably humans.

Abstract: The present invention relates to the use of compounds which act as agonists at atypical beta-adrenoceptors, for the treatment of gastrointestinal disorders, especially peptic ulceration, oesophagitis, gastritis and duodenitis, intestinal ulcerations, including inflammatory bowel disease, and gastrointestinal ulcerations, especially when induced by non-steroidal anti-inflammatory drugs or corticosteroids.

Abstract: The present invention relates to a composition useful for hepatoprotection, said composition comprising polar extract of plant Cryptolepis Buchanani and/or fractions of the said extract, and optionally pharmaceutically acceptable additives and a method of producing said composition and also a method of treating a subject using said composition.

Abstract: The present invention relates to the derivatives of specially substituted azole compounds which have improved antifungal activity as compared to known compounds such as fluconazole and itraconazole and the processes for the preparation thereof. This invention also relates to pharmaceutical compositions containing the compounds of the present invention and their use in treating and/or preventing fungal infections in mammals, preferably humans.

Abstract: The present invention relates to a composition useful for hepatoprotection, said composition comprising polar extract of plant Cryptolepis Buchanani and/or fractions of the said extract, and optionally pharmaceutically acceptable additives and a method of producing said composition and also a method of treating a subject using said composition.

Abstract: Pharmaceutical composition and a method useful for treating immunodeficiency in animals or human beings, said composition comprising effective amount of the extract obtained from any part of plant Cryptolepis buchanani, either as such or its individual constituents singly or in composition with each other, optionally associated with pharmaceutically acceptable additives.

Abstract: The present invention relates to the derivatives of specially substituted azole compounds which have improved antifungal activity as compared with presently available agents in this class and the processes for the preparation thereof. This invention also relates to pharmaceutical preparations containing the compounds of the present invention and their use in treating and/or preventing the fungal infections in mammals, preferably humans.

Abstract: The invention disclosed relates to a nanofiltration composite membrane that is solvent and pH stable and may be used to separate at least one dissolved or suspended component from a liquid phase, including(a) a substrate ultrafiltration membrane formed from an ethylenically unsaturated nitrile, such as acrylonitrile and substituted acrylonitrile polymers, and(b) a coating of a hydrophilic polymer containing reactive functional groups.Preferably, the reactive functional groups described in (b) are subjected to a post-coating cross-linking reaction with a substantially non-cytotoxic cross-linking agent such as bi-functional aldehydes. A method for the preparation of such composite membranes is also disclosed.